{
     "PMID": "18593508",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20080924",
     "LR": "20161124",
     "IS": "1461-1457 (Print) 1461-1457 (Linking)",
     "VI": "11",
     "IP": "5",
     "DP": "2008 Aug",
     "TI": "Olanzapine, but not haloperidol, enhances PSA-NCAM immunoreactivity in rat prefrontal cortex.",
     "PG": "591-5",
     "LID": "10.1017/S1461145708009061 [doi]",
     "AB": "Repeated antipsychotic treatment may produce adaptive changes ranging from cytoarchitectural rearrangements to synaptic modifications that might contribute to clinical improvement. We performed a prolonged treatment (2 wk) with the first-generation antipsychotic (FGA) haloperidol (1 mg/kg) and the second-generation antipsychotic (SGA) olanzapine (2 mg/kg twice daily) and analysed the expression of the polysialylated form of neural cell adhesion molecule (PSA-NCAM) in rat hippocampus and prefrontal cortex via immunohistochemistry. We found a regional- and drug-selective increase of PSA-NCAM expression in prefrontal cortex of olanzapine-treated rats with no effects in hippocampus; conversely, haloperidol did not produce a change in either brain region. Our findings reveal a possible role for PSA-NCAM in the mechanism of action of the SGA olanzapine adding complexity as well as specificity to the molecular changes set in motion by this drug.",
     "FAU": [
          "Frasca, Angelisa",
          "Fumagalli, Fabio",
          "Ter Horst, Judith",
          "Racagni, Giorgio",
          "Murphy, Keith J",
          "Riva, Marco A"
     ],
     "AU": [
          "Frasca A",
          "Fumagalli F",
          "Ter Horst J",
          "Racagni G",
          "Murphy KJ",
          "Riva MA"
     ],
     "AD": "Center of Neuropharmacology, Department of Pharmacological Sciences, University of Milan, Milan, Italy.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "Int J Neuropsychopharmacol",
     "JT": "The international journal of neuropsychopharmacology",
     "JID": "9815893",
     "RN": [
          "0 (Dopamine Antagonists)",
          "0 (Neural Cell Adhesion Molecule L1)",
          "0 (Serotonin Uptake Inhibitors)",
          "0 (Sialic Acids)",
          "0 (polysialyl neural cell adhesion molecule)",
          "12794-10-4 (Benzodiazepines)",
          "J6292F8L3D (Haloperidol)",
          "N7U69T4SZR (olanzapine)"
     ],
     "SB": "IM",
     "MH": [
          "Analysis of Variance",
          "Animals",
          "Benzodiazepines/*pharmacology",
          "Cell Count/methods",
          "Dopamine Antagonists/*pharmacology",
          "Haloperidol/*pharmacology",
          "Male",
          "Neural Cell Adhesion Molecule L1/*metabolism",
          "Prefrontal Cortex/*drug effects/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Serotonin Uptake Inhibitors/*pharmacology",
          "Sialic Acids/*metabolism"
     ],
     "EDAT": "2008/07/03 09:00",
     "MHDA": "2008/09/25 09:00",
     "CRDT": [
          "2008/07/03 09:00"
     ],
     "PHST": [
          "2008/07/03 09:00 [pubmed]",
          "2008/09/25 09:00 [medline]",
          "2008/07/03 09:00 [entrez]"
     ],
     "AID": [
          "S1461145708009061 [pii]",
          "10.1017/S1461145708009061 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Int J Neuropsychopharmacol. 2008 Aug;11(5):591-5. doi: 10.1017/S1461145708009061.",
     "term": "hippocampus"
}